These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 2532753)
1. Cerebral glucose consumption measured by PET in patients with and without psychiatric symptoms of Huntington's disease. Kuwert T; Lange HW; Langen KJ; Herzog H; Aulich A; Feinendegen LE Psychiatry Res; 1989 Sep; 29(3):361-2. PubMed ID: 2532753 [No Abstract] [Full Text] [Related]
2. Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of Huntington's disease. Kuwert T; Noth J; Scholz D; Schwarz M; Lange HW; Töpper R; Herzog H; Aulich A; Feinendegen LE Mov Disord; 1993; 8(1):98-106. PubMed ID: 8419813 [TBL] [Abstract][Full Text] [Related]
3. Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan. Kuhl DE; Phelps ME; Markham CH; Metter EJ; Riege WH; Winter J Ann Neurol; 1982 Nov; 12(5):425-34. PubMed ID: 6217782 [TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography in the early diagnosis of Huntington's disease. Hayden MR; Martin WR; Stoessl AJ; Clark C; Hollenberg S; Adam MJ; Ammann W; Harrop R; Rogers J; Ruth T Neurology; 1986 Jul; 36(7):888-94. PubMed ID: 2940474 [TBL] [Abstract][Full Text] [Related]
5. Cerebral involvement in systemic lupus erythematosus (SLE): comparison of positron emission tomography (PET) with other imaging methods. Meyer GJ; Schober O; Stoppe G; Wildhagen K; Seidel JW; Hundeshagen H Psychiatry Res; 1989 Sep; 29(3):367-8. PubMed ID: 2608795 [No Abstract] [Full Text] [Related]
6. [SPECT studies with 99mTc-HMPAO in Huntington's chorea patients]. Botsch H; Oepen G; Deuschl G; Wolff G Rofo; 1987 Dec; 147(6):666-8. PubMed ID: 2827263 [TBL] [Abstract][Full Text] [Related]
7. Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease. Grafton ST; Mazziotta JC; Pahl JJ; St George-Hyslop P; Haines JL; Gusella J; Hoffman JM; Baxter LR; Phelps ME Arch Neurol; 1992 Nov; 49(11):1161-7. PubMed ID: 1444883 [TBL] [Abstract][Full Text] [Related]
8. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease. Antonini A; Leenders KL; Spiegel R; Meier D; Vontobel P; Weigell-Weber M; Sanchez-Pernaute R; de Yébenez JG; Boesiger P; Weindl A; Maguire RP Brain; 1996 Dec; 119 ( Pt 6)():2085-95. PubMed ID: 9010012 [TBL] [Abstract][Full Text] [Related]
9. PET and neuropsychology in thalamic infarction: evidence for associated cortical dysfunction. Hennerici M; Halsband U; Kuwert T; Steinmetz H; Herzog H; Aulich A; Feinendegen LE Psychiatry Res; 1989 Sep; 29(3):363-5. PubMed ID: 2608794 [No Abstract] [Full Text] [Related]
10. Functional caudate imaging in symptomatic Huntington's disease: positron emission tomography versus single-photon emission computed tomography. Martin WR; Hoskinson M; Kremer B; Maguire C; McEwan A J Neuroimaging; 1995 Oct; 5(4):227-32. PubMed ID: 7579751 [TBL] [Abstract][Full Text] [Related]